Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: A pilot study

Obesity Surgery

Volumn 18, Issue 4, 2008, Pages 401-407

  Topazian, Mark ^a   Camilleri, Michael ^a   De La Mora Levy, Jose ^a   Enders, Felicity B ^a   Foxx Orenstein, Amy E ^a   Levy, Michael J ^a   Nehra, Vandana ^a   Talley, Nicholas J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Botulinum toxin; Endoscopic ultrasound; Gastric emptying; Obesity; Satiation

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; BACKACHE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; DRINKING; DRUG TOLERABILITY; ENDOSCOPIC ECHOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROSCOPY; HUMAN; MALE; NAUSEA; OBESITY; OPEN STUDY; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; SATIETY; STATISTICAL SIGNIFICANCE; STOMACH ANTRUM; STOMACH EMPTYING; STOMACH SCINTISCANNING; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOSONOGRAPHY; FEMALE; GASTRIC EMPTYING; GASTRIC MUCOSA; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; OBESITY; PILOT PROJECTS; SATIATION; WEIGHT LOSS;

EID: 43349105217     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9442-x     Document Type: Article

References (29)

1. Steinbrook R. Surgery for severe obesity. N Engl J Med. 2004;350:1075-9.
2. Padwal R, Majumdar S. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007;369:71-7.
3. James A, Ryan J, Parkman H. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle. Am J Physiol Gastrointest Liver Physiol. 2003;285:G291-7.
4. Coskun H, Duran Y, Dilege E, Mihmanli M, Seymen H, Demirkol M. Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model. Obes Surg. 2005;15:1137-43.
5. Cardoso Junior A, Savassi-Rocha P, Vaz Coelho L, de Mello Sposito M, Albuquerque W, Costa Diniz M, et al. Botulinum A toxin injected into the gastric wall for the treatment of class III obesity: a pilot study. Obes Surg. 2006;16:335-43.
6. Albani G, Petroni M, Mauro A, Liuzzi A, Lezzi G, Verti B, et al. Safety and efficacy of therapy with botulinum toxin in obesity: a pilot study. J Gastroenterol. 2005;40:833-5.
7. Delgado-Aros S, Cremonini F, Castillo J, Chial H, Burton D, Ferber I, et al. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004;126:432-40.
8. Gui D, Mingrone G, Valenza V, Spada P, Mutignani M, Runfola M, et al. Effect of botulinum toxin antral injection on gastric emptying and weight reduction in obese patients: a pilot study. Aliment Pharmacol Ther. 2006;23:675-80.
9. Mittermair R, Keller C, Geibel J. Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg. 2007;17:732-6.
10. Rollnik JD, Manns MP, Goke M. Antral injections of botulinum A toxin for the treatment of obesity. Ann Intern Med. 2003;138:359-60.
11. Foschi D, Corsi F, Lazzaroni M, Sangaletti O, Riva P, La Tartara G, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. Int J Obes. 2007;31:707-12.
12. Schurch B, Stohrer M, Kramer G, Schmid D, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164:692-7.
13. Cremonini F, Mullan B, Camilleri M, Burton D, Rank M. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther. 2002;16:1781-90.
14. Tack J, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346-52.
15. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastro. 1995;30:1046-52.
16. Dimenas E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol. 1993;28:681-7.
17. Talley N, Fullerton S, Junghard O, Wiklund I. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001;96:1998-2004.
18. Hodis H, Mack W, Lobo R, Shoupe D, Sevanian A, Mahrer P, et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001;135:939-53.
19. Camilleri M, Malagelada J, Brown M, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol. 1985;249:G580-5.
20. Camilleri M, Brown M, Malagelada J. Relationship between imparied gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986;91:94-9.
21. Qureshi W. Gastrointestinal uses of botulinum toxin. J Clin Gastroenterol. 2002;34:126-8.
22. Lacy B, Crowell M, Schettler-Duncan A, Mathis C, Pasricha P. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care. 2004;27:2341-7.
23. Sampaio C, Ferreira J, Simoes F, Rosas M, Magalhaes M, Correia A, et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-Dysport and Botox-assuming a ratio of 4:1. Mov Disord. 1997;12:1013-8.
24. Garcia-Compean D, Mendoza-Fuerte E, Martinez J, Villarreal I, Maldonado H. Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol Clin Biol. 2005;29:789-91.
25. Delgado-Aros S, Camilleri M, Castillo E, Cremonini F, Stephens D, Ferber I, et al. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol. 2005;3:997-1006.
26. Wadden T, Berkowitz R, Womble L, Sarwer D, Phelan S, Cato R, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353:2111-20.
27. Berkowitz R, Fujioka K, Daniels S, Hoppin A, Owen S, Perry A, et al. Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med. 2006;145:81-90.
28. Abbruzzese G, Berardelli A. Neurophysiological effects of botulinum toxin type A. Neurotox Res. 2006;9:109-14.
29. Botulinum toxin type A: drug information. UpToDate Online version 14.3 2006.